Mass loss rate of marble under different chemical environments and dry-wet cycle conditions. by Yongsheng Liu (142720)

Subjects:

Stress-strain curves. by Yongsheng Liu (142720)

Subjects:

Dissipated energy ratio. by Yongsheng Liu (142720)

Subjects:

Mass damage rate under different pH values and dry-wet cycles. by Yongsheng Liu (142720)

Subjects:

Patterns of energy changes in marble samples and their stress-strain curves under dry-wet cycles. by Yongsheng Liu (142720)

Subjects:

Relationship between dissipation energy and elastic strain energy. by Yongsheng Liu (142720)

Subjects:

Mechanical parameter trends under different chemical environments and wet-dry cycles. by Yongsheng Liu (142720)

Subjects:

ZTRE-210 Microcomputer Control Rock Triaxial Test System. by Yongsheng Liu (142720)

Subjects:

Marble specimens. by Yongsheng Liu (142720)

Subjects:

Mechanical parameters of marble under different chemical environments and dry-wet cycle conditions. by Yongsheng Liu (142720)

Subjects:

Changes in circulatory variables during CPB. by Vincent Pey (21433304)

Table 1_Association between serum anion gap trajectory and mortality in hospitalized patients with sepsis: an analysis of the MIMIC-IV database.docx by Lijuan Jing (20431757)

“…Background<p>Sepsis remains a leading cause of mortality in intensive care units (ICUs), with high morbidity and healthcare costs worldwide. The serum anion gap (AG), a marker of metabolic acidosis, has been associated with adverse outcomes in various critical illnesses. …”

Evolution of arterial redox potential during CPB. by Vincent Pey (21433304)

NLSs can significantly impact intranuclear stages of HIV-1 infection. by Nicholas Rohlfes (20577485)

“…Results in A,B,D and F (mean ± SEM) are representative from 3 independent experiments with at least technical duplicates. …”

Changes in connectivity of the mPFC among responders and non-responders. by Karel Joineau (21799908)

Subjects:

Data supporting this article. by Karel Joineau (21799908)

Subjects:

CONSORT diagram showing the flow of participants through each stage of the DOREPAR randomized trial for the main outcome (change of VAS). by Karel Joineau (21799908)

Subjects:

Demographic and clinical data at baseline. by Karel Joineau (21799908)

Subjects:

Changes in clinical variables. by Karel Joineau (21799908)

Subjects:

Change of functional connectivity in the SMN after intervention. by Karel Joineau (21799908)

Subjects: